# Aardvark Therapeutics

> Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biopharmaceutical company
> developing novel small-molecule therapies designed to inhibit hunger and treat metabolic
> disease. Its lead candidate, ARD-101, is an oral, gut-restricted agonist of bitter taste
> receptors (TAS2Rs) on the luminal side of the intestine that triggers the release of satiety
> hormones to suppress hunger signaling. Aardvark Therapeutics is a drug-development
> organization and publishes no public API, SDK, developer portal or machine-readable
> specification. This file was generated by API Evangelist from publicly reachable pages; it is
> not published by the company.

## Company

- [Home](https://aardvarktherapeutics.com/): Company overview and the hunger-versus-appetite thesis behind the pipeline.
- [Science](https://aardvarktherapeutics.com/science/): Mechanism of action — TAS2R bitter taste receptor agonism and satiety hormone release.
- [Programs](https://aardvarktherapeutics.com/programs/): Development pipeline, including ARD-101 for hyperphagia in Prader-Willi Syndrome.
- [Team](https://aardvarktherapeutics.com/team/): Leadership and scientific team.
- [In the News](https://aardvarktherapeutics.com/in-the-news/): Company announcements and press coverage.
- [Contact](https://aardvarktherapeutics.com/contact/): General company contact.

## Investors

- [Investor Relations](https://ir.aardvarktherapeutics.com/): Nasdaq: AARD — news releases, financial results and SEC filings.

## Legal

- [Privacy Policy](https://aardvarktherapeutics.com/legal/privacy-policy/)
- [Terms of Use](https://aardvarktherapeutics.com/legal/terms-of-use/)
- [CCPA Notice](https://aardvarktherapeutics.com/legal/ccpa/)

## Developer surface

There is none. As of 2026-08-06 the following were probed on aardvarktherapeutics.com and all
returned 404: /openapi.json, /openapi.yaml, /swagger.json, /api-docs, /docs, /redoc, /api,
/developers, /llms.txt, /.well-known/security.txt, /.well-known/openid-configuration,
/.well-known/oauth-authorization-server, /.well-known/api-catalog, /.well-known/ai-plugin.json,
/.well-known/agent-card.json and /.well-known/agent.json. No OpenAPI, AsyncAPI, GraphQL SDL, MCP
server, A2A agent card, SDK or package-registry client library exists. The company's GitHub
organization (https://github.com/Aardvark-Therapeutics) is real and first-party but publishes
zero public repositories.

## Disambiguation

Several unrelated organizations share the "Aardvark" name and DO publish developer surfaces.
None of them is Aardvark Therapeutics:

- Aardvark Communications (aardvarktx.com) — a Texas marketing agency; serves an llms.txt.
- Total Phase Aardvark (totalphase.com) — an I2C/SPI host adapter with a Python API.
- Aardvark (aardvark.sh) — a messaging platform with a beta developer portal.

## About this file

- [API Evangelist profile](https://apis.io/provider/aardvark-therapeutics/)
- Generated: 2026-08-06 | Method: generated | Source: apis.yml + probed public pages